Navigation Links
Newly issued USPSTF Guidelines for Colorectal Cancer include complete line of products from Polymedco
Date:6/21/2016

CORTLANDT MANOR, N.Y., June 21, 2016 /PRNewswire/ -- Polymedco announced today that its OC-Auto® family of FIT products and Epi proColon® (Epigenomics) blood test for colorectal cancer screening have both been classified as Grade A recommended screening tests by the United States Preventative Services Task Force (USPSTF) in the recommendation statement released on June 21, 2016. Grade A recommendation is defined as: "The USPSTF recommends the service. There is high certainty that the net benefit is substantial." The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years.

The USPSTF states the OC-Auto {OC FIT-CHEK family of FITs (Polymedco)}—which include the OC-Light and the OC-Auto—have the best test performance characteristics (ie, highest sensitivity and specificity).

The USPSTF names Epi proColon ("SEPT9 DNA test") as one of several screening tests for the detection of early-stage colorectal cancer.

According to the USPSTF, screening for colorectal cancer is a substantially underused preventive health strategy in the United States. In addition, there are no empirical data to suggest that any of the strategies provide a greater net benefit. Accordingly, the best screening test is the one that gets done, and the USPSTF concludes that maximizing the total proportion of the eligible population that receives screening will result in the greatest reduction in colorectal cancer deaths.

Polymedco believes that the new USPSTF guidelines will result in higher screening rates with OC-Auto® and Epi proColon® modalities and supports the American Cancer Society and NCCRT's combined goal of achieving 80% of the population screened by 2018.

About OC-Auto®: Polymedco is the leader in FIT testing, with the first FDA cleared automated FIT analyzer, OC-Auto®, the high throughput automated FIT analyzer OC-Auto® Sensor Diana, and the recently cleared OC-Light® S FIT manual point of care test. Single sample, no dietary restrictions, ease of use, and customized patient packs all increase patient compliance.

About Epi proColon®: Epi proColon is an in-vitro PCR (polymerase chain reaction) assay for the qualitative detection of Septin9 gene methylation in DNA isolated from the patient's plasma. Cytosine residues of the Septin9 gene are methylated in colorectal cancer tissue, but not in normal colon mucosa. This tumor-specific methylation pattern can be used to detect cell-free DNA shed into the blood stream by tumor cells. Detection of colorectal cancer-derived DNA in blood plasma using the Septin9 methylation biomarker has been demonstrated in multiple clinical studies to be a reliable indicator of the presence of colorectal cancer. Epi proColon has received approval from the U.S. Food and Drug Administration (FDA) and is currently marketed in the United States by Polymedco CDP, LLC.

About Polymedco: Since 1980, Polymedco has evolved into a leading manufacturer, marketer, and distributor in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits that are specialized in hematology and cancer screening. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC-Auto® and OC-Light® product lines.

Polymedco Cancer Diagnostic Products, LLC.
510 Furnace Dock Road
Cortlandt Manor, NY  10567  USA
Telephone: 800-431-2123
Facsimile: 914-739-5890

OC-Auto and OC-Light are Registered Trademarks of Polymedco CDP, LLC.

Epi proColon is a Registered Trademark of Epigenomics, AG

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/newly-issued-uspstf-guidelines-for-colorectal-cancer-include-complete-line-of-products-from-polymedco-300288003.html


'/>"/>
SOURCE Polymedco
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Baxalta Presents Additional Data on Newly-Approved ADYNOVATE and Plans for New Indications During 57th American Society of Hematology (ASH) Annual Meeting
2. On World AIDS Day, Mylan Announces Plans to be the First to Market Newly-Recommended Antiretroviral Treatment for $99 Per Patient, Per Year
3. Figure 1 Launches Newly Rebuilt Web Version With Enhanced Functionality For Radiologists
4. Family Rentals Announces Launch of Newly Designed, Mobile-Responsive Website
5. ImmunoCellular Therapeutics to Host Conference Call and Webcast to Discuss ICT-107 Program in Newly Diagnosed Glioblastoma on November 24, 2015
6. Gaumards Latest UNI Operating System Is Compliant with Newly Released 2015 AHA CPR/ECC Guidelines
7. Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients
8. Patterson Medical Positioned for Continued Growth as a Newly Independent Company
9. CASI Pharmaceuticals Appoints Leading Oncology Experts To Newly Formed Clinical Advisory Board
10. LCMC Health Selects Omnicell Medication Automation and Workflow Solutions for Newly Constructed University Medical Center Scheduled to Open in Summer 2015
11. Makindus Appoints World Renowned Experts on Stargardt Disease to Newly Formed Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought ... This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at ... towards children of all ages; it is a non-competitive, non-timed event, which is all ...
(Date:10/13/2017)... ... ... Talented host, actor Rob Lowe, is introducing a segment ... of "Success Files," which is an award-winning educational program broadcasted on PBS Member ... with passion and integrity. , Sciatica occurs when the sciatic nerve in the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
Breaking Medicine News(10 mins):